Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.

Erlotinib can cause hair loss and texture changes.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

The new palladium catalyst is effective and reusable for making pharmaceutical ingredients.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Nanocarriers with spironolactone and 2-deoxy-D-ribose may improve hair loss treatment by targeting hair follicles directly.

Baricitinib can cause excessive hair growth.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.